|
mTOR inhibitors: Temsirolimus and everolimus in the treatment of renal cell ... - UroToday |
|
|
|
UroTodayTemsirolimus has shown in a randomized phase III trial for patients with poor risk feature of metastatic renal cell carcinoma, a significant gain in overall ... |
|
ATS Publishes Joint Statement on Renal Failure in the ICU Patient - Newswise (press release) |
|
|
|
Newswise (press release)In fact, acute renal failure is one of the biggest threats to critically ill patients: forty percent of patients with this condition die. ... |